Home / Compliance actions / 696742

FDA Warning Letter — ProRx LLC

Case 696742 — FEI 3022250654

The FDA took a Warning Letter action against ProRx LLC on Dec 20, 2024 (Exton, PA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
ProRx LLC
Date
Dec 20, 2024
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Exton, PA (United States)

Facility

Recent inspections

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.